Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockers
JoAnn Lindenfeld, MD, FACC*,a,
Alastair D. Robertson, PhDa,
Brian D. Lowes, MD, FACCa,
Michael R. Bristow, MD, PhD, FACCa for the MOCHA Investigators
a Division of Cardiology, University of Colorado Health Sciences Center, Denver, Colorado, USA
View larger version (20K):
[in a new window]
|
Figure 1 Changes in left ventricular ejection fraction (LVEF) in all patients, in carvedilol-treated patients and in placebo-treated patients.
|
|
View larger version (21K):
[in a new window]
|
Figure 2 Changes in heart rate. Groups as in Figure 1.
|
|
View larger version (22K):
[in a new window]
|
Figure 3 Changes in systolic blood pressure. Groups as in Figure 1.
|
|
View larger version (13K):
[in a new window]
|
Figure 4 Change with left ventricular ejection fraction (LVEF) in aspirin users and nonusers.
|
|
|
